ALHC

Alignment Healthcare, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-02-27

Figures on this page computed 2026-11-08 12:55 UTC

Last close

7.56USD

Market data, 2026-11-05

ALHC: weekly closes from 15.73 on 2026-05-15 to 7.56 on 2026-11-05, a move of -51.9%. Prices in USD.

Weekly closes, 2026-05-15 to 2026-11-05

Over that span: -51.9%

Except where said otherwise: 10-K for 2025, filed 2026-02-27

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001628280-26-012545
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-27
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001628280-26-012545
Reported in
USD
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
- 10-Q for 2025, filed 2026-10-29
- 10-K for 2025, filed 2026-02-27
- 10-Q for 2025, filed 2026-10-29
The filing itself
-0.02%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001628280-26-012545
Reported in
USD
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
The filing itself
2.9%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001628280-26-012545
Reported in
USD
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
The filing itself
1.85Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001628280-26-012545
Reported in
USD
- 10-K for 2025, filed 2026-02-27
- 10-Q for 2025, filed 2026-10-29
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Safety is the furthest below its sector's middle: 0.36 against 0.57 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

2.16x

0.01x

-7.82x

1.50x

0.58x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-05

Each against its own average

5 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-02-27

Sales2.16x
Its own average over 7 years, 1.83B.
Profit0.01x
Its own average over 7 years, -98.5M.
Free cash flow-7.82x
Its own average over 4 years, -14.5M.
Debt1.50x
Its own average over 6 years, 220.6M.
Price0.58x
Its own average over 6 years, 13. Market data, 2026-11-05

Free cash flow is furthest from its own average, at -7.82 times.

The filed years, as a table

Each line is 100 at 2019-12-31, the first year we hold.

Filed year	Sales
2019-12-31	100.0
2020-12-31	126.7
2021-12-31	154.3
2022-12-31	189.5
2023-12-31	240.9
2024-12-31	357.2
2025-12-31	521.7

How sales was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0001628280-26-012545
Reported in: USD

The filing itself

Figures behind the shape

Growth

32.7%

faster is higher, placed against 4,950 companies as of 2026-11-07

Five-year revenue growth rate32.7%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
One-year change in net income99.4%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Returns on capital

-0.4%

higher is higher, placed against 5,089 companies as of 2026-11-07

Return on invested capitaln/a
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001628280-26-012545
Reported in
USD
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
- 10-Q for 2025, filed 2026-10-29
- 10-K for 2025, filed 2026-02-27
- 10-Q for 2025, filed 2026-10-29
The filing itself
Return on equity-0.4%
Net Income / Shareholders' Equity x 100
Source
computed
Fiscal year
2025
Accession
0001628280-26-012545
Reported in
USD
- 10-K for 2025, filed 2026-02-27
- 10-Q for 2025, filed 2026-10-29
The filing itself
Return on assets-0.1%
Net Income / Total Assets x 100
Source
computed
Fiscal year
2025
Accession
0001628280-26-012545
Reported in
USD
- 10-K for 2025, filed 2026-02-27
- 10-Q for 2025, filed 2026-10-29
The filing itself

Margins

0.4%

wider is higher, placed against 3,412 companies as of 2026-11-07

Gross marginn/a
We do not hold this figure for this company, so there is nothing to place.
Gross Profit / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001628280-26-012545
Reported in
USD
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
The filing itself
Operating margin0.4%
Operating Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001628280-26-012545
Reported in
USD
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
The filing itself
Net margin-0.02%
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001628280-26-012545
Reported in
USD
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
The filing itself
Free cash flow margin2.9%
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001628280-26-012545
Reported in
USD
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
The filing itself

Price

8.1x

cheaper is higher, placed against 4,362 companies as of 2026-11-07

Price to earningsn/a
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001628280-26-012545
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-27
The filing itself
Price to book8.1x10-Q for 2025, filed 2026-10-29
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
Source
computed
Fiscal year
2025
Accession
0001628280-26-068247
Reported in
USD
- computed
- 10-Q for 2025, filed 2026-10-29
- computed
- 10-K for 2025, filed 2026-02-27
The filing itself
EV to EBITDA26.8x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001628280-26-012545
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
- 10-Q for 2025, filed 2026-10-29
- 10-K for 2025, filed 2026-02-27
The filing itself
Price to sales ratio0.4x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
Source
computed
Fiscal year
2025
Accession
0001628280-26-012545
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
The filing itself

Safety

1.85

safer is higher, placed against 3,227 companies as of 2026-11-07

Debt to equity1.85
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001628280-26-012545
Reported in
USD
- 10-K for 2025, filed 2026-02-27
- 10-Q for 2025, filed 2026-10-29
The filing itself
Current ratio1.7110-Q for 2025, filed 2026-10-29
Current Assets / Current Liabilities
Source
computed
Fiscal year
2025
Accession
0001628280-26-068247
Reported in
USD
- 10-Q for 2025, filed 2026-10-29
- 10-Q for 2025, filed 2026-10-29
The filing itself
Interest coverage0.9x
Operating Income / Interest Expense
Source
computed
Fiscal year
2025
Accession
0001628280-26-012545
Reported in
USD
- 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
The filing itself
Altman Z-Score3.85
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
Source
computed
Taken on
2026-11-07
Reported in
USD
- Computed from the 10-K for 2025, filed 2026-02-27
- Computed from the 10-K for 2025, filed 2026-02-27
- Computed from the 10-K for 2025, filed 2026-02-27
- Computed from the 10-K for 2025, filed 2026-02-27
- Computed from the 10-K for 2025, filed 2026-02-27

What it pays out

n/a

We do not hold this figure for this company, so there is nothing to place.

more, and better covered, is higher, with no cohort held

Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
Source
computed
Fiscal year
2025
Accession
0001628280-26-012545
Reported in
USD
- 10-K for 2025, filed 2026-02-27
- Computed from the 10-K for 2025, filed 2026-02-27
- 10-K for 2025, filed 2026-02-27
The filing itself
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Share a finding

A link to the finding, not to you: it carries nothing about your account.